Hepatitis C, Peginterferon und Depression: welche Behandlung?
نویسندگان
چکیده
منابع مشابه
Peginterferon and ribavirin for chronic hepatitis C.
n engl j med 355;23 www.nejm.org december 7, 2006 2444 This Journal feature begins with a case vignette that includes a therapeutic recommendation. A discussion of the clinical problem and the mechanism of benefit of this form of therapy follows. Major clinical studies, the clinical use of this therapy, and potential adverse effects are reviewed. Relevant formal guidelines, if they exist, are p...
متن کاملNeue Entwicklungen in der Demenzdiagnostik und -behandlung
New Developments in Diagnosis and Treatment of Dementia. New diagnostic research criteria were established 2007. In the past 8 years the International Working Group (IWG) and the NIA have contributed criteria for the diagnosis of AD that better define clinical phenotypes and integrate biomarkers into staging of the diagnostic process, covering the full staging of the disease. The newest DSM-5 i...
متن کاملBehandlung semantischer Heterogenität durch Metadatenextraktion und Anfragetransfers
The project CARMEN (“Content Analysis, Retrieval and Metadata: Effective Networking”) aimed among other goals at improving the expansion of searches in bibliographic databases into Internet searches. We pursued a set of different approaches to the treatment of semantic heterogeneity (meta-data extraction, query translation using statistic relations and cross-concordances). This paper describes ...
متن کاملShortened peginterferon and ribavirin treatment for chronic hepatitis C.
BACKGROUND Peginterferon alfa and ribavirin combination therapy is an effective treatment for many patients with chronic hepatitis C virus (HCV). Reducing the length of treatment may be advantageous. We performed a systematic review and economic evaluation to assess shorter treatment duration of this regimen. METHODS We searched fourteen bibliographic databases (including The Cochrane Library...
متن کامل[Peginterferon alpha-2b in patients with chronic hepatitis C].
150 adult patients were assigned pegylated interferon alpha-2b (once weekly 1.5 microg/kg) plus ribavirin (800-1200 mg depending on bodyweight). The treatment lasted 52 weeks and was completed by 139 persons (92.7%). Because of adverse events the treatment was interrupted in 7 persons, 4 other persons resigned. Periodical reduction of pegylated interferon doses was necessary in 19% and the redu...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Swiss Medical Forum ‒ Schweizerisches Medizin-Forum
سال: 2012
ISSN: 1424-4020,1424-3784
DOI: 10.4414/smf.2012.01243